Patents by Inventor Rodger Anthony Allen

Rodger Anthony Allen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Specific trifluoroethyl quinoline analogue for use in the treatment of Sjögren's syndrome
    Patent number: 10493074
    Abstract: N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of Sjögren's syndrome.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: December 3, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Rodger Anthony Allen, Francesca Barone, William Anthony Fahy, Saba Nayar
  • A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment of APDS
    Publication number: 20190209567
    Abstract: N—{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of activated phosphoinositide 3-kinase delta syndrome (APDS).
    Type: Application
    Filed: May 15, 2017
    Publication date: July 11, 2019
    Inventors: Rodger Anthony Allen, Martin John Armstrong, Marina Cavazzana, Sven Kracker, Duncan Philip McHale, Andrew Charles Payne
  • A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment Of Sjögren's Syndrome
    Publication number: 20180092921
    Abstract: N-{(R)-1-[8-Chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of Sjögren's syndrome.
    Type: Application
    Filed: April 20, 2016
    Publication date: April 5, 2018
    Inventors: Rodger Anthony Allen, Francesca Barone, William Anthony Fahy, Saba Nayar